Skip to content

Advertisement

Open Peer Review Reports for: The multikinase inhibitor Sorafenib displays significant antiproliferative effects and induces apoptosis via caspase 3, 7 and PARP in B- and T-lymphoblastic cells

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
27 May 2010 Submitted Original manuscript
30 Jul 2010 Reviewed Reviewer Report - James Mier
10 Aug 2010 Reviewed Reviewer Report - Pier Giorgio Petronini
16 Aug 2010 Reviewed Reviewer Report - Paola Ulivi
16 Aug 2010 Reviewed Reviewer Report - Roberto R. Rosato
10 Sep 2010 Author responded Author comments - Christian Junghanss
Resubmission - Version 2
10 Sep 2010 Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
15 Sep 2010 Author responded Author comments - Christian Junghanss
Resubmission - Version 4
15 Sep 2010 Submitted Manuscript version 4
Publishing
15 Oct 2010 Editorially accepted
15 Oct 2010 Article published 10.1186/1471-2407-10-560

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement